Oncolytic activity of respiratory syncytial virus against prostate cancer
呼吸道合胞病毒对前列腺癌的溶瘤活性
基本信息
- 批准号:7564763
- 负责人:
- 金额:$ 20.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:A549AgeAgingAndrogensAnimalsAntineoplastic AgentsAntiviral AgentsAntiviral ResponseApoptosisAttenuatedBiological AssayBody partBreastC57BL/6 MouseCancer EtiologyCell LineCell NucleusCellsCellular biologyCessation of lifeClinical TrialsColon CarcinomaCritiquesDU145DataData AnalysesDefectDiseaseDistalDoseDown-RegulationElderlyElderly manEpithelial CellsEvaluationFamily memberFeedbackFigs - dietaryFutureGene ExpressionHistologyHomingHumanHuman respiratory syncytial virusImageIn SituIn VitroInfectionLAPC4LNCaPLifeLungMalignant NeoplasmsMalignant neoplasm of prostateMeasuresMediatingMetastatic Prostate CancerModelingMucous MembraneMusNamesNatural ImmunityNormal CellNude MiceOncolyticOncolytic virusesOrganPC3 cell linePancreasPathway interactionsPopulationPrimary NeoplasmPrincipal InvestigatorProductionPropertyProstateProstatic NeoplasmsProteinsPublicationsPublished CommentPublishingReaction TimeRegulationReportingResourcesRespiratory Syncytial Virus InfectionsRespiratory syncytial virusRoleSafetySignal TransductionSiteSmall Interfering RNASolid NeoplasmSubfamily lentivirinaeSystemic infectionTNF geneTherapeuticVertebratesViralViral GenesViral Load resultVirulentVirusVirus DiseasesVirus ReplicationWestern BlottingXenograft procedurebasebonecancer cellcancer riskcancer therapycell killingchromatin immunoprecipitationcytokinedesigndisorder controlin vivokillingsknock-downmalemenmortalitymouse modelneoplastic cellnonhuman primatenoveloncolysisprogramspublic health relevanceresearch studyresponseskeletaltooltumortumor specificitytumor xenografttumorigenicvector
项目摘要
DESCRIPTION (provided by applicant): Prostate cancer is a malignant tumor, which in its aggressive form would spread to the bone and many other parts of the body. The aging male population is especially susceptible to this disease, since from the 5th decade of life the prostate cancer risk rises steadily. In fact, ~ 60% new cases of solid tumors in men over age 70 represent tumors in the prostate gland. Metastatic prostate cancer is the leading cause of cancer deaths among elderly men. The proposed study is expected to provide novel information on the strategy to manage prostate cancer based on selective killing of prostate tumor cells by the oncolytic human respiratory syncytial virus (RSV). Oncolytic virotherapy is an emerging bio-therapeutic platform for cancer treatment, which is based on selective infection and "killing" of cancer cells. To date, eight oncolytic viruses have been identified. However, recent clinical trials indicated the need for a multi-virus virotherapy approach for the treatment of aggressive cancers and thus, the urgency to identify novel oncolytic viruses. To this end, we have identified RSV as a novel oncolytic virus, since RSV possesses potent anti-cancer activity against prostate tumor cells. Our results demonstrated dramatic enhancement of RSV infectivity in the androgen-insensitive, highly metastatic PC-3 human prostate cancer cells compared to the non-tumorigenic RWPE-1 human prostate cells. The enhanced viral burden in PC-3 cells leads to selective "killing" of PC-3 cancer cells in vitro and in vivo in human prostate tumor xenografts grown in nude mice. We further demonstrated that the possible mechanism underlying the oncolytic function of RSV involves defect in the NF-?B dependent innate anti-viral response in PC-3 cells. Since anti-viral innate immunity constitutes the first line of defense directed to restrict viral infection, we speculate that dysfunctional innate response in PC-3 cells is responsible for the increased viral infectivity and oncolysis. The proposed study will be pursued with two Specific Aims: Aim 1) Characterize the RSV-mediated oncolysis of prostate cancer cells in vivo in tumor xenografts and in the TRAMP mouse model of prostate cancer. Aim 2) Study the role of the deregulated NF-?B dependent anti-viral pathway in conferring the oncolytic function to RSV in prostate cancer cells. RSV-mediated oncolysis in vivo will be assessed based on tumor regression; prostate histology; apoptosis in situ; and metastatic spread of PC-3 cells in a fluorescent orthotopic model. Deregulated NF-?B function will be explored using cell biology approaches including knock down of specific NF-?B family members by lentivirus-mediated siRNA expression and chromatin immunoprecipitation. Significance: The oncolytic property of RSV could be developed as an efficient therapeutic tool to specifically target prostate tumors. PUBLIC HEALTH RELEVANCE: Prostate cancer is a leading cause of mortality among elderly population and novel anti-cancer treatment is necessary to control this disease. We have identified respiratory syncytial virus as a novel anti-cancer agent that could selectively destroy prostate cancer cells, but not normal cells. Therefore, this virus could be utilized as a therapeutic to design safe and efficient virus-based anti-cancer agents to specifically target prostate tumors.
描述(由申请人提供):前列腺癌是一种恶性肿瘤,其侵袭性形式会扩散到骨骼和身体的许多其他部位。老年男性特别容易患这种疾病,因为从五岁开始,前列腺癌的风险稳步上升。事实上,70 岁以上男性中约 60% 的新实体瘤病例是前列腺肿瘤。转移性前列腺癌是老年男性癌症死亡的主要原因。拟议的研究有望为基于溶瘤人类呼吸道合胞病毒(RSV)选择性杀死前列腺肿瘤细胞的前列腺癌治疗策略提供新的信息。溶瘤病毒疗法是一种新兴的癌症治疗生物治疗平台,其基于选择性感染和“杀死”癌细胞。迄今为止,已鉴定出八种溶瘤病毒。然而,最近的临床试验表明需要一种多病毒病毒疗法来治疗侵袭性癌症,因此迫切需要鉴定新型溶瘤病毒。为此,我们将 RSV 确定为一种新型溶瘤病毒,因为 RSV 对前列腺肿瘤细胞具有有效的抗癌活性。我们的结果表明,与非致瘤性 RWPE-1 人前列腺细胞相比,雄激素不敏感、高度转移性 PC-3 人前列腺癌细胞中 RSV 感染性显着增强。 PC-3细胞中病毒负荷的增加导致在体外和体内在裸鼠中生长的人前列腺肿瘤异种移植物中选择性“杀死”PC-3癌细胞。我们进一步证明RSV溶瘤功能的可能机制涉及PC-3细胞中NF-κB依赖性先天抗病毒反应的缺陷。由于抗病毒先天免疫构成了限制病毒感染的第一道防线,因此我们推测 PC-3 细胞中功能失调的先天反应是病毒感染性和溶瘤作用增加的原因。拟议的研究将有两个具体目标: 目标 1) 在肿瘤异种移植物和前列腺癌 TRAMP 小鼠模型中表征体内 RSV 介导的前列腺癌细胞溶瘤作用。目标 2) 研究失调的 NF-κB 依赖性抗病毒途径在赋予前列腺癌细胞 RSV 溶瘤功能中的作用。 RSV介导的体内溶瘤作用将根据肿瘤消退进行评估;前列腺组织学;原位细胞凋亡;以及荧光原位模型中 PC-3 细胞的转移扩散。将使用细胞生物学方法探索失调的 NF-κB 功能,包括通过慢病毒介导的 siRNA 表达和染色质免疫沉淀敲低特定的 NF-κB 家族成员。意义:RSV 的溶瘤特性可开发为一种有效的治疗工具,专门针对前列腺肿瘤。公共卫生相关性:前列腺癌是老年人群死亡的主要原因,需要新的抗癌治疗来控制这种疾病。我们已经确定呼吸道合胞病毒是一种新型抗癌剂,可以选择性地破坏前列腺癌细胞,但不能破坏正常细胞。因此,这种病毒可以用作治疗剂,设计安全有效的基于病毒的抗癌剂,专门针对前列腺肿瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Santanu Bose其他文献
Santanu Bose的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Santanu Bose', 18)}}的其他基金
Mycoplasma pneumoniae CARDS toxin mediated ADP-ribosylation of NLRP3 inflammasome
肺炎支原体卡毒素介导的 NLRP3 炎性体 ADP 核糖基化
- 批准号:
8903838 - 财政年份:2015
- 资助金额:
$ 20.03万 - 项目类别:
Mycoplasma pneumoniae CARDS toxin mediated ADP-ribosylation of NLRP3 inflammasome
肺炎支原体卡毒素介导的 NLRP3 炎性体 ADP 核糖基化
- 批准号:
9001254 - 财政年份:2015
- 资助金额:
$ 20.03万 - 项目类别:
Host defense against respiratory virus infections
宿主防御呼吸道病毒感染
- 批准号:
8828325 - 财政年份:2010
- 资助金额:
$ 20.03万 - 项目类别:
Host defense against respiratory virus infections
宿主防御呼吸道病毒感染
- 批准号:
8075435 - 财政年份:2010
- 资助金额:
$ 20.03万 - 项目类别:
Host defense against respiratory virus infections
宿主防御呼吸道病毒感染
- 批准号:
7793021 - 财政年份:2010
- 资助金额:
$ 20.03万 - 项目类别:
Host defense against respiratory virus infections
宿主防御呼吸道病毒感染
- 批准号:
8279249 - 财政年份:2010
- 资助金额:
$ 20.03万 - 项目类别:
Host defense against respiratory virus infections
宿主防御呼吸道病毒感染
- 批准号:
8662164 - 财政年份:2010
- 资助金额:
$ 20.03万 - 项目类别:
Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection
模式识别受体激活和呼吸道病毒感染过程中调节先天免疫和炎症的分子和细胞机制
- 批准号:
9759740 - 财政年份:2010
- 资助金额:
$ 20.03万 - 项目类别:
Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection
模式识别受体激活和呼吸道病毒感染过程中调节先天免疫和炎症的分子和细胞机制
- 批准号:
10190789 - 财政年份:2010
- 资助金额:
$ 20.03万 - 项目类别:
Host defense against respiratory virus infections
宿主防御呼吸道病毒感染
- 批准号:
8473154 - 财政年份:2010
- 资助金额:
$ 20.03万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 20.03万 - 项目类别:
Operating Grants